Life Sciences Archive » November, 2009

Life Sciences - November, 2009

181 articles

• Calif. Court Cuts McKesson Penalty From $15M To $2M
• Abbott Settles TriCor Patent Spat With Teva
• High Court Mulls Statute Of Limitations In Investor Suits
• Invisalign Wins Right To Amend In Battle With Counsel
• Depomed Fingers Lupin In Diabetes Drug Patent Case
• NJ Law To Govern Punitives In Zometa, Aredia Cases
• Contract Claims V. Mayo Nixed In Alzheimer's IP Spat
• Punitive Damages Fight Revived In ObTape Case
• High Court Refuses Cordis, Boston Scientific Appeals
• Wyeth V. Levine Won't Affect Liability Win For Perrigo
• Generic-Drug Labels Must Provide Warnings: 8th Circ.
• Stryker To Buy Medical Device Reprocessor For $525M
• Wrongful Death Suit Over J&J's Remicade Closed
• Daiichi Sankyo Goes After Sandoz For Evoxac ANDA
• Consolidated Defendants Tossed From Colchicine Spat
• QLT Settles Visudyne Royalty Spat For $20M
• The Complications Of Successorship Decisions
• GSK Prevails In Sales Rep Overtime Suit
• Wal-Mart, CVS Win Bid To Toss Drug Overcharge Suit
• Ex-Taro Exec, Son Hit With Penalties In SEC Case
• Court Affirms St. Jude Win In Noncompete Dispute
• GSK Pulls H1N1 Vaccine Amid Reports Of Reactions
• Reconsidering Re-Examination — 10 Years Of Data
• Jury Tacks On $28M In Punitive Damages For Pfizer
• J&J Wants Consumer Class Tossed From AWP Suit
• Dow Corning Sues Merrill Over $166M In Failed ARS
• FDA Launches Safety Review Of Weight Loss Drug
• Merck Wins Bid To Toss Texas Medicaid Fraud Suit
• 2nd Bellwether Case Over Merck's Fosamax Nixed
• Zicam Maker Urges FDA To Reverse Anosmia Finding
• Medical Ed. Co. Says Ex-Worker Stole Source Codes
• $125M Deal Awaits OK In Bristol-Myers Class Action
• 1st Circ. Crushes Objection To $24M Zoladex Deal
• Pfizer Hit With $6.3M Prempro Verdict In Pa.
• P&G Recalls Nasal Spray Over Bacteria Risk
• Teva Will Appeal Loss In Vigamox Eyecare Patent Suit
• Exela Takes Alphagan Patent Ruling To Fed. Circ.
• FDA Enforcement Heating Up
• St. Jude Wins Motion To Recover Stolen Trade Secrets
• Novartis Wins Herpes Drug Patent Fight Against Teva
• Sheppard Mullin Lures IP Expert From Kelley Drye
• EU To Request Drug Patent Deal Details
• ARS Investor Seeks To Dump FINRA As Arbitrator
• OraSure To Pay $3M To Settle HIV Test Patent Suit
• Sughrue Mion Grabs Calif. Biotech Patent Attorney
• 9th Circ. Allows CTI Contract Dispute To Go Forward
• Congress Demands Health Insurers Explain Rate Hikes
• Plavix Label Revised To Include Prilosec Warning
• Bayer, GE, Covidien MRI Agents Carry Higher Risk: FDA
• House Dems Ask GAO To Look At Drug Prices
• FDA Warns Medtronic Over Heart Rhythm Unit
• Edwards Drags Medtronic To Court Over Valve Patent
• The Reluctance To Certify Mass Class Under CAFA
• PRE Loses Injunction Bid In Device Patent Suit
• US Seeks OK For $6M Ill. Contamination Settlement
• Norbrook, Boehringer End Dog Drug IP Brawl
• The Bifurcation Divide
• Teva Drops 2 Copaxone Claims Against Sandoz
• DeCode Files For Ch. 11 With Plan To Sell Assets
• CSI Recalls Sheath Introducers Amid Breakage Fears
• Seroquel Plaintiffs Rebuked Over Video Testimony Bid
• Streck Appeals Conflicting Patent Board Finding
• Importer Seeks Lower Duty On Vitamin Pills
• Takeda Appeals Win For Teva In Generic Prevacid Case
• Smith & Nephew Not Enjoined In Wound Therapy IP Suit
• Seller Of Fake Cancer Drugs Loses Bid For New Trial
• FDA Warns Abbott To Fix 'Adulterated' Devices
• McDermott Adds Darby & Darby Attys To NY IP Team
• Stanford Receiver Looks To Sell Sinking Investments
• Eli Lilly Escapes Suit Over Prozac Slaying, Suicide
• Dermatological Patent Spat Ends In Settlement
• AstraZeneca Fights Bid To Videotape Seroquel Expert
• High Court Will Not Review Bra-Tank Top Case
• Class Certified In Abbott Contact Lens Solution Suit
• Wyeth, Schwarz Off Hook In Generic Reglan Suit
• Arnold & Porter Snags Veteran Appellate Lawyer
• Bristol-Myers To Divest Mead Johnson Stake
• Class Cert. Bid Nixed In J&J Panacryl Sutures MDL
• J&J Appeals Loss In CIBA Contact Lens Patent Suit
• W.Va. Plaintiffs To Fight Baycol MDL Ruling In 8th Circ.
• 9th Circ. Revives Amgen Drug Rebates Dispute
• More Bodybuilding Products Recalled Over Steroids
• Fed Circ. Refuses To Nix Injunction On USPTO Rules
• Dey, Others Fork Over $4.3M To End Iowa AWP Suit
• 8th Circ. Upholds Tossing Of Baycol Expert Testimony
• Frommer Bumped From Merck, ProThera Patent Suit
• Cephalon, Barr Settle Fentora Patent Battles
• FDA Warns Public About Post-Surgery Infusions
• Generics Maker Says Drug-Safety Program Gets Abused
• Arthrex Hit With Patent, Trade Secrets Claims
• New USPTO Director Wastes No Time Making Mark
• FDA Issues Safety Warning About 5 Genzyme Drugs
• WL Gore, Synovis End Feud Over Staple Seal Patent
• Wage-And-Hour Issues In The Life Sciences Industry
• 7th Circ. To Review Medicare Contract Antitrust Spat
• Abbott Gains Pain-Relief Drug In $190M Deal
• Growing Safe Food Act Vows Aid To Small Farms
• Pfizer Looks To Shake PCB Pollution Claims
• Endo To Pay $23M To Settle Patent Suit Over Patch
• Class Action Alleges Plot To Price-Fix Plasma Therapies
• St. Jude Parries Insurer's Bid To Sidestep Coverage
• ARS Investor Fights To Keep Citigroup In Court
• Lilly To Pay Utah $24M Over Zyprexa Marketing
• BPA MDL Against Bottle Makers Survives Bid To Toss
• Teva Launches Generic Prevacid After Patent Win
• Different FDA Regs For Devices, Drugs Rule Preemption
• Knobbe Martens Nabs Ex-Ranbaxy VP Of Global IP
• Biovail Accuses Elan, Fournier Of Misleading USPTO
• Foley Lures Sheppard Mullin IP Chair To San Diego
• Merck Answers USPTO In Singulair Patent Re-Exam
• Conceptus Fails To Block Rival Contraceptive System
• Fraud Claims Cut From Actimmune Marketing MDL
• Threshold Settles Shareholder Action For $10M
• Bilski Argument Puts Spotlight On Business Methods
• Hospital Wage-And-Hours The Next Wave, Lawyers Say
• Celexa, Lexapro Deal Covers Civil Claims Only
• Sonova Snaps Up Advanced Bionics For $489M
• Takeda Sues Teva Over Sleeping Pill ANDA
• Plaintiffs' Demand For Docs Too Late In Seroquel MDL
• Ark. High Court Tosses Nexium Marketing Fraud Suit
• Allergan Hits Alcon With Combigan Patents
• House Passes Health Care Bill
• Ill. Cancer Hospital Hit With Whistleblower Suit
• Antitrust Concerns Revived As CVS Reveals FTC Probe
• Plaintiffs Drop Lipitor Class Action Against Pfizer
• Boston Scientific To Pay $296M To Settle Probe
• DOJ Probes Abbott's Sales, Marketing Of Depakote
• Mirapex Buyers Bid For Class Status In Antitrust Case
• Infosint Seeks $43M Damages In Citalopram Suit
• $1.7B Centocor Patent Award Against Abbott Stands
• Troutman Atty Tagged In $50M Omnicare Scheme
• Feds Search Rothstein's Firm In Missing Funds Probe
• P&G Sued Over Vicks With Vitamin C Products
• Ropes & Gray Atty Charged In Insider Trading Probe
• Insurers Shouldn't Fear New FTC Powers, Attys Say
• TPG Capital, Pension Plan To Buy IMS Health For $5B
• McKesson Wins Bid For Discovery Docs In AWP Fight
• Investors Slap Hansen Medical With Securities Action
• Centurion Recalls Kits With Faulty Tracheal Tubes
• Firms Say Industry Focuses Offer Edge In M&A Work
• Shire Settles With Apotex Over Epilepsy Patents
• After Jury Win, Patent Board Turns Tables On Streck
• Mutual Pharma Sanctioned In Sulindac Suit
• AtriCure To Pay $4M Over Ablation Device Marketing
• Pfizer Prempro Verdict Rumored To Be $75M
• ICL Sues Hawkins Over Failed Food Additive Deal
• Commerce Hails White House Pick For Export Post
• American Regent Expands Pain Injection Vial Recall
• Novartis Strikes $125M Deal For Chinese Vaccine Co.
• Online Vendor Recalls Supplements Over Steroids
• House Dems Amend Health Bill As Vote Approaches
• Differential Diagnosis — Trending Toward Exclusion
• Illumina Hits Affymetrix Over New Gene Tech Patent
• Kaiser Appeals Abbott MDL Antitrust Patent Case
• USPTO's Rescission Of Controversial Patent Rules
• Judge Pares Down Indirect Buyers' Wellbutrin Action
• Tender Offer Makes A Comeback
• Supreme Court Braces For Bilski Battle
• Omnicare, Teva Unit End Kickback Claims For $112M
• Cooley Lures Pillsbury Venture Capital Guru
• Sanofi, Bristol-Myers Try To Quash Apotex Subpoenas
• Rothstein Rosenfeldt Sues Partner Over Ponzi Scheme
• Breast Cancer Gene Patent Case Survives Bids To Toss
• Allergan Lashes Out At Eye Center In Patent Dispute
• Roche Drops NJ Boniva Suits After Teva Pulls ANDA
• FTC Extends Scrutiny Of MDS' $650M Sale To Danaher
• Neuralstem Loses Bid To Toss Stem Cell Patent Case
• Did SCOTUS Kill Product Design Trade Dress?
• Streck Wins Patent Suit Over Hematology Technology
• DOJ Targets Canadian Textile Co. Over Defective Zylon
• FDA Issues Warning Over Eli Lilly Diabetes Drug Byetta
• High Court Asks Solicitor General For Brief In Pfizer Suit
• 8th Circ. OKs $27M Damages Dismissal In Prempro Case
• FSI Hit With Fine Over Valve, Pump Export Violations
• Lilly To Appeal Invalidity Ruling For Sun In Gemzar Suit
• Supreme Court Declines Apotex Appeal Of Plavix Suit
• Conn. AG To Look Into Flu Vaccine Price-Gouging
• PerkinElmer Had Duty To Promote Printing Unit: 1st Circ.
• High Court Rebuffs Rx.com's Group Boycott Suit
• Purdue Hits Cipher With Patent Suit Over Ultram
• Solvay Wants Androgel Indirect Purchaser Cases Axed